Trial Profile
Open-label, randomised, multi-center study investigating Cetuximab, in combination with concurrent chemo- / radiotherapy in locally advanced non-small cell lung carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms RADITUX
- 10 Sep 2019 Results of health related quality of life presented at the 20th World Conference on Lung Cancer
- 09 Sep 2015 Results of 60 months follow up presented at the 16th World Conference on Lung Cancer
- 05 Jun 2012 Efficacy outcomes presented at the 48th Annual Meeting of the American Society of Clinical Oncology.